Letters XX in blue and orange followed by the letter combinator

We won't stop until we find and fund the next

five

healthtech unicorns for women

Top pharma companies derive more than 60 percent of their revenue from therapies for diseases that affect women uniquely, differently, or disproportionately

— McKinsey & Company, 2025

Femtech is forecasted to reach $60bn+ TAM by 2027

-Allied Market Research, 2023

closing the women’s health gap could unlock $400 billion in global GDP annually by 2040

-World Economic Forum, 2025

recent news

Women's Health Founders:

Intimate Funding & Connection Session

Women's Health Morning Walk & Coffee